The PD-L1/B7-H1 antigen is preferentially expressed in many different types of cancer cells but minimally expressed on normal tissues [16], indicating its potential as an ideal target for designing CAR-T cells to combat multiple solid tumors [18–20]. The gene discussed is CD274; the disease is cancer.